chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient was sitting in our lobby following covid vaccination when he reported he felt a little dizzy and thought he may faint, (patient was nervous for the vaccine prior to administration), I sent someone to grab a  ice pack and a bottle of water for him and while they were retrieving the ice pack he started to seize. Patient was breathing but unresponsive, stiff, and unable to blink, talk, or move for around 2-3 minutes.  Once the seizure ended I asked patient if he had a history of seizures, his answer was, "not really". He drank some of the water and sat with the ice pack for a couple minutes and said he felt better. Color returned. Patient stated he felt nerves contributed more than anything and was feeling 100% better when he left. We had dialed 911 while patient was unresponsive but once he was able to talk again he declined 911 and stated feeling much better.
Immunization given on 01/05/05 pt returned to clinic 1/7/05 in AM. Childs arm is slightly, swollen at deltoid area, area is warm to the touch, reactive erythema noted covering right deltoid. Pts mother advises she has been applying cold packs and alternating Motrin and Tylenol.
2 RNs I work with got their 2nd dose and tested positive for COVID the same week.; 2 RNs I work with got their 2nd dose and tested positive for COVID the same week.; This is a spontaneous report from a contactable nurse. This was one of two reports. A patient of unknown age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration as a single dose and first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration as a single dose, both the doses for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The reporter reported that 2 RNs I work with got their 2nd dose and tested positive for COVID the same week (as reported). The outcome for the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: The contribution of the suspect drug to the onset of event 'drug ineffective' cannot be ruled out since drug efficacy varies from one patient to another and affected by different factors.,Linked Report(s) : US-PFIZER INC-2021328276 same reporter, drug and AE, different patient
Mild joint pain in left hip which started about 3 days after second vaccine. Followed by joint pain in knuckles of right hand which started 3 weeks after 2nd dose of pfizer BioNTech vaccine. Seemed to be an immune flare- for 1-2 weeks my knuckles ached and it hurt to grip a car steering wheel. Then my hands turned red and emanated heat. The flare seemed to end and my knuckles have gotten much better but my hip pain persists even though it has been months since the second vaccine. It especially hurts when I first get up, and seems to improve slightly when I move around more. When I was experiencing the knuckle pain I went to my PCP and was checked for Rheumatoid arthritis and lupus and had my hand x-rayed. All testing came back normal.
This spontaneous report was received from a physician via company representatives referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 13-OCT-2014, the patient was vaccinated with an improperly stored dose of (23-valent) PNEUMOVAX 0.5 ml (VIs 10 SDV) (Lot number K007822, expiration date 15-AUG-2015), single dose, route and anatomical location were not provided. There was no concomitant medication provided. No adverse effects were reported. On an unknown date, the (23-valent) PNEUMOVAX had a temperature excursion for 312 hours, the lowest recorded temperature was 20 degrees F (-6.667 Celsius). The vaccine status was reported and "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". There was no product quality complaint involved. This is one of several cases received from the same reporter. Additional information has been requested.
This case was reported by a consumer via sales rep and described the occurrence of injection site pain in a male patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (For tolerance refer case US2019GSK053659). On an unknown date, the patient received the 2nd dose of SHINGRIX (intramuscular). On an unknown date, unknown after receiving SHINGRIX, the patient experienced injection site pain and general body pain. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the injection site pain and general body pain were unknown. It was unknown if the reporter considered the injection site pain and general body pain to be related to SHINGRIX. Additional details were reported as follows: This case was reported by the patient's son at conference, medical booth. The patient's age at vaccination was not reported. The patient received SHINGRIX (timing unknown) and experienced local pain at the site of injection that progressed throughout his body. This case has been linked to case US2019GSK053659, reported for the dose 1 of the same patient.
Information has been received from a nurse referring to an unknown number of patients of unknown age and gender. In 2015 these patients were vaccinated with doses of M-M-R II (lot #K011317 with expiration 13-JUN-2016; dose, frequency and route were not reported) which has been improperly stored since January 2015 (incorrect product storage). No adverse effects were reported. This is one of several cases received from the same source. Additional information has been requested.
Vaccine was used on 16 October for doses after expired date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was used on 16 October for doses after expired date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was used on 16 October for doses after expired date). On 16-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine was used on 16 October for doses after expired date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided. Dose administered after 30-day Use By Date or after manufacturer date of expiry. The vial was initially stored in the refrigerator on 10 September 2021.The temperature range of the refrigerator was from 33-38 degrees Fahrenheit. As per pharmacist the vial didn't undergo any temperature excursions.   This case was linked to MOD-2021-359827, MOD-2021-359782 (Patient Link).
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On 08-SEP-2014, the patient was vaccinated with a dose of GARDASIL and with another dose on 25-MAR-2015. Dosage, lot numbers, route of administration were not reported. No adverse symptoms were reported. Additional information has been requested.
After having received my second shingles shot on Wednesday I woke up the next morning with a headache, a fever, and a queasy stomach.   I slept about 24 hours straight and was back to normal this morning.  I guess I'm one of the "one in six" who experience such symptoms.   (a number I learned just now from the CDC website).   Only had a sore arm on the first shingles shot.    No need to contact my doctor or the pharmacy on this - just wanted to report my experience.
Day of injection 10-16-06 Felt sore, 10-17-06 Ache, feverish took tylenol, still feverish yesterday 10-18-06.  Continued to be sensitive at site of injection left arm. 10-19-06 seen by provider for above, treatment-no more td recommendation by provider.
I experienced irregular heart beats, palpitations.  I obtained a 12 lead.  Called my doctor and have a cardiologist consult in late February.  The palpitations started after the 1st shot in the series, and after the 2nd shot they increased.
Syncope and vomiting after receiving vaccines.  Cold cloth to head, water, lollipop. Did not require ammonia inhalant. BP 101/65.
This spontaneous report a received from a licensed practical nurse refers to multiple patients of an unknown age and gender. No information regarding the patients' concurrent conditions and medical history was provided. On an unknown dates, the patients were vaccinated with an unspecified number of doses of improperly stored PNEUMOVAX 23 (dose, route of administration, lot# and expiration date were not reported). The patients' concomitant therapy was not reported. There were no adverse effects reported. Product quality complaint was not involved. This is one of several reports received from the same source. Additional information has been requested.
Low grade temp, rash, fatigue, anorexia, cervical adenopathy immun 6MAR91, seen by MD 19MAR91; supportive rx only given;
Baby came back after about 15 min with face flushed, no rash/lip swelling/diff breath/swallow. no wheeze. alert and comfortable child. physical exam- unremarkable other than face looked congested. observed in clinic for 30 min, and vitals and exam done again, no issues. sent home with ER precautions and call /Return to clinic precautions. not heard back for any immediate Follow up for any reaction to clinic/ER.  later the child was seen at 6 mt wcc by other provider, and parent mentioned about the earlier event, and provider referred the child to Allergy and immunology and who seen the child.
Paleness/weakness after vaccination, no loss of consciousness, skin warm and dry. Respirations non-labored. No AOX3 distress. Layed down, elevated feet. fluid given. Symptoms resolved. BP 100/70. 2 wks numbness/tingling - strength good, equal, no distress. Ambulates independently.
2 red stripes around neck, swollen lips, breathing is shallow & difficult occurred 7 days p/each inject 16JUN last react
Slight headache on Day 1 Day 3 - headache, excessively tired, nausea & diarrhea.  Worsened throughout the day
This case was reported by a nurse and described the occurrence of an injection site reaction in a 4 year old patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed (Infanrix).  On an unspecified date in July 2004, the patient received the fifth dose of Infanrix in the leg (lot DTPA590B9).  The day after the vaccine was received, on an unspecified date in July 2004, the patient experienced an injection site reaction characterized as redness and inflammation.  The patient was seen at a physician's office.  The outcome of the events is unknown.  The nurse considered the injection site reaction to probably be related to vaccination with Infanrix.
My husband developed rigors, aches, chills, sweats and fever of 102 around 10am  on 12/15/2021 and self treated wtih OTC Tylenol around the clock since would spike a fever when the Tylenol wore off. He woke up on 12/16/21 at 2:45am with severe rigors, chills, aches and temperature of 102.4 and got up to take more Tylenol when he had syncope and collapse. Syncope was witnessed by me (wife) and my husband fell and lost consciousness for about 30 seconds. Since it was dark and he fell behind the bed, I heard a "thud" but was not sure if he hit his head and found him supine, groaning with eyes open on the floor but not responsive. My husband was out of it for a little but regained consciousness fairly quickly and did not feel the syncopal episode come on.  He finished taking Tylenol and felt better once his fever broke about 30 minutes later.
I developed a knee effusion in my left knee with considerable swelling. I saw an orthopedist who could not determine a cause. It has been subsiding slowly over the course of a week and a half with care at home.
No adverse event; Moderna Covid 19 Bivalent vaccine which was administered 16 hours after first puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid 19 Bivalent vaccine which was administered 16 hours after first puncture) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 022H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Jan-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 20-Jan-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid 19 Bivalent vaccine which was administered 16 hours after first puncture). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid 19 Bivalent vaccine which was administered 16 hours after first puncture) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna Covid 19 Bivalent vaccine which was administered 16 hours after first puncture).    No concomitant medications were reported. No treatment information was provided.
On day 2,  Feb. 7, 2021 at 7am when I got up to go to bathroom I was dizzy. The dizziness lasted until noon. After that I was fine, had breakfast and drank alot of water.
Driving home from appt, daughter said she didn't feel well, was cold & felt like throwing up.  I looked at her & she was completely white.  Brought her back to clinic & they said she stressed herself out.  But looking back now I think it was definitely more than that.
36 hours after the injection I developed large red, warm and painful area at the injection site. 24 hours after that I was experiencing fever and chills again. I also started to vomit
Pt woke up the next morning with ear ache. Woke up another day and thought she had a crick in her neck. GOt to where she couldn't move her shoulder. Is seeing dr.
Generalized muscle ache and soreness, most noticeable on between knee to hip, and in shoulders.
Patient presented to clinic for COVID 19 booster and was given a full-dose Moderna vaccine.  RN left voicemail notifying patient of dosing error and to call with questions/concerns.
pt recv vax 8AUG95 & devel fever as high as 103, typical discrete, red maculopapular rash all over body,bluish white spots in mouth, vesicles on posterior pharynx, runny nose, cough, diarrhea, loss of appetite & lethargic;
This spontaneous report was received from a pharmacist referring to multiple unspecified patients of unknown age and gender. The patients' pertinent medical history, drug reaction/allergies or concomitant medication were not reported. On an unknown dates, the patients were vaccinated with improperly stored doses of ZOSTAVAX (route, dose, lot # and expiration date were not reported). The pharmacist confirmed that the ZOSTAVAX went through defrost cycling (temperature, time frame and amount of cycles unspecified). No adverse event was reported. There was any product quality complaint (PQC) involved. Additional information has been requested.
This spontaneous report was received from a medical assistant refers to an unspecified number of patients of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On an unspecified dates, in 2015, reported as "starting on or after 18-MAR-215", the patients were vaccinated with unspecified improperly stored doses of PROQUAD (Merck) (route of administration, anatomical location, lot number and expiration date were not provided). There were no concomitant medications reported. No adverse effect reported. There was no product quality issue involved. This is one of two cases from the same reporter. Additional information has been requested.
No adverse event; a patient was administered one dose of improperly stored PNEUMOVAX 23; This spontaneous report was received a registered nurse referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, drug reactions /allergies and concomitant medications was not provided.  On 22-APR-2019, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (Lot # R027299, expiration date 09-APR-2022) route of administration and anatomical location were not reported for prophylaxis. No adverse effects were reported.  The time frame was 10 minutes in a temperature above 47 F (70 F), no previous temperature excursion was reported, the call was because data logger. No product quality complaint was involved.
No further adverse effect reported; patient received a dose of improperly stored ROTATEQ; Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported.  On 20-FEB-2020, the patient received a dose of ROTATEQ (strength, dose detail and route were not reported) (lot # S014947, expiration date 10-DEC-2020) for prophylaxis, which was reported as improperly stored (temperature below 36 degrees Fahrenheit (34 Fahrenheit), time frame was 27 minutes) (product storage error). There was no previous temperature excursion. Data logger was involved. No further adverse effect was reported.
Information has been received from a licensed practical nurse concerning an 8 year old male with no drug allergies and no medical histories who on 20-NOV-2003 was vaccinated with the first dose of VARIVAX (Merck) (therapy route and lot # not provided). On 04-SEP-2007 he was vaccinated with the second dose of VARIVAX (Merck) (therapy route and lot # not provided). There was no concomitant medication. On 07-MAR-2011 the patient presented to the licensed practical nurse's practice with multiple lesions characteristic of chicken pox. The patient's mother stated that the lesions began to appear two days prior to the office visit, on 05-MAR-2011. The patient, who was otherwise "healthy", was started on KEFLEX 500 mg to prevent secondary infection and was being referred to an infectious disease specialist. No lab diagnostics studies were performed. At the time of reporting, the patient's status was recovering. Additional information has been requested.
Patient came to the pharmacy for his second Shingrix shot and an Influenza shot.  Patient was given Shingrix and Boostrix (tetanus-diphtheria) shot in error. Patient was told of the event and immediately given a Flulaval (influenza) shot as well.
ONSET OF REACTION WAS "LATE NIGHT"  ON THE DAY OF VACCINATION - STAFF BEGAN HAVING HEART PALPITATIONS AND TACHYCARDIA. MD NOTIFIED OF SYMPTOMS AND ADVISED STAFF TO GO TO THE ER. STAFF WENT TO THE ER. DISCOVERED TO HAVE VERY HIGH BLOOD PRESSURE.  WAS GIVEN 2 BAGS OF IV FLUIDS AND 3 DOSES OF "BLOOD PRESSURE MEDICATION" BEFORE BLOOD PRESSURE WAS CONSIDERED STABLE, PULSE REMAINED TACHYCARDIC. AFTER ABOUT 6 HOURS, SHE WAS DISCHARGED WITH INSTRUCTIONS TO F/U WITH PRIMARY MD, IF CONDITION PERSISTED. STAFF REPORTED FEELING MUCH BETTER UPON DISCHARGE AND NOT REPORTED ANY FURTHER EPISODES OR REACTIONS.
B/P 160/110 11/09, 140/90 11/10 at private physician and office extremely tired, had diarrhea 11/04 et felt ill, Sunday 11/05 felt fine 11/06 feet and legs throbbing, no temp, still has frontal headache, left arm sore, achy, throbbing x 4 days
Pt received FLUMIST 10-4-14 4-5 hours after receiving FLUMIST pt vomited 2x.
pain in arm; redness; swelling; This case was reported by a nurse via sales rep and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain in arm, erythema and swelling. On an unknown date, the outcome of the pain in arm, erythema and swelling were recovered/resolved.   It was unknown if the reporter considered the pain in arm, erythema and swelling to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The patient experienced arm pain, redness and swelling that lasted almost 10 days on 1st dose.
Very swollen, painful, large lymph node on left collarbone. It moves around when touched. This same thing happened when I got my second shot. This side effect should be more publicized, especially since this same sort of event can be a sign of cancer.